The Incretin market is a subset of the larger Diabetes Drugs market. Incretin drugs are a class of medications used to treat type 2 diabetes. They work by stimulating the release of insulin from the pancreas in response to meals, and by reducing the production of glucose by the liver. Incretin drugs are typically taken orally, and are often used in combination with other diabetes medications. The Incretin market is highly competitive, with a number of major pharmaceutical companies offering products. These companies are investing heavily in research and development to create new and improved treatments. Some of the major companies in the Incretin market include Novo Nordisk, Eli Lilly, Merck, AstraZeneca, and Boehringer Ingelheim. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
